Logo image of KLRS

KALARIS THERAPEUTICS INC (KLRS) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:KLRS - US4829291065 - Common Stock

5.885 USD
-0.04 (-0.59%)
Last: 12/5/2025, 8:00:02 PM
Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to KLRS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 17.34. This target is 194.65% above the current price.
KLRS was analyzed by 11 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about KLRS.
In the previous month the buy percentage consensus was at a similar level.
KLRS was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
KLRS Historical Analyst RatingsKLRS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 5.895.0520.4017.3424.15 - -14.19% 246.64% 194.65% 310.37%
KLRS Current Analyst RatingKLRS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-11-03 Citizens Initiate Market Outperform
2025-09-03 Raymond James Initiate Strong Buy
2025-04-08 William Blair Initiate Outperform

KALARIS THERAPEUTICS INC / KLRS FAQ

What is the average price target for KALARIS THERAPEUTICS INC (KLRS) stock?

11 analysts have analysed KLRS and the average price target is 17.34 USD. This implies a price increase of 194.65% is expected in the next year compared to the current price of 5.885.


Can you provide the consensus rating for KALARIS THERAPEUTICS INC stock?

The consensus rating for KALARIS THERAPEUTICS INC (KLRS) is 85.4545 / 100 . This indicates that analysts generally have a positive outlook on the stock.